Prudential Financial Inc. Lowers Position in HealthEquity, Inc. (NASDAQ:HQY)

Prudential Financial Inc. trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 38.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,773 shares of the company’s stock after selling 6,008 shares during the quarter. Prudential Financial Inc.’s holdings in HealthEquity were worth $963,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in HQY. Centiva Capital LP acquired a new position in HealthEquity in the 3rd quarter worth about $366,000. State Street Corp increased its position in shares of HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after buying an additional 23,613 shares in the last quarter. EP Wealth Advisors LLC acquired a new position in shares of HealthEquity during the 3rd quarter worth approximately $340,000. Zacks Investment Management lifted its position in shares of HealthEquity by 10.8% during the 3rd quarter. Zacks Investment Management now owns 31,456 shares of the company’s stock valued at $2,575,000 after buying an additional 3,059 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in HealthEquity by 5.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company’s stock valued at $7,510,000 after acquiring an additional 4,878 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of research analyst reports. KeyCorp reduced their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Monday, March 24th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price target for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company boosted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Finally, Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity has an average rating of “Buy” and an average target price of $112.58.

HealthEquity Stock Up 2.0 %

Shares of HQY opened at $80.36 on Tuesday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $101.18 and a two-hundred day simple moving average of $96.48. The company has a market capitalization of $6.95 billion, a PE ratio of 73.72, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.